Document and Entity Information
Document and Entity Information | Dec. 11, 2020 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 11, 2020 |
Entity Registrant Name | Odonate Therapeutics, Inc. |
Entity Central Index Key | 0001717452 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38318 |
Entity Tax Identification Number | 82-2493065 |
Entity Address, Address Line One | 4747 Executive Drive |
Entity Address, Address Line Two | Suite 210 |
Entity Address City Or Town | San Diego |
Entity Address State Or Province | CA |
Entity Address Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 731-8180 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security12b Title | Common Stock, $0.01 par value per share |
Trading Symbol | ODT |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |